Prosecution Insights
Last updated: April 19, 2026

Lunella Biotech Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18425427 TRIPLE COMBINATION THERAPIES FOR ANTI-AGING OLSON, ANDREA STEFFEL 1693 Non-Final OA Jan 29, 2024
18541733 SELECTIVE CDK 4/6 INHIBITOR CANCER THERAPEUTICS VALENROD, YEVGENY 1628 Non-Final OA Dec 15, 2023
17748354 MITORIBOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING CANCER CELLS, BACTERIA, AND PATHOGENIC YEAST DRAPER, LESLIE A ROYDS 1629 Non-Final OA May 19, 2022

Managing Lunella Biotech Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month